<DOC>
	<DOCNO>NCT02345421</DOCNO>
	<brief_summary>The objective study determine frequency Lysosomal Acid Lipase Deficiency ( LAL D ) lysosomal acid lipase ( LAL ) enzyme activity assay patient consider risk .</brief_summary>
	<brief_title>A Study Identify Characterize LAL-D Patients High-risk Populations</brief_title>
	<detailed_description />
	<mesh_term>Wolman Disease</mesh_term>
	<criteria>1 . Nonobese** patient elevate lowdensity lipoprotein ( LDL ) 2 . Nonobese** patient low highdensity lipoprotein ( HDL ) 3 . Nonobese** patient unexplained persistently elevate liver transaminase , 4 . Nonobese** patient hepatomegaly 5 . Patients cryptogenic cirrhosis 6 . Patients biopsyproven microvesicular mixed micro/macrovesicular steatosis without know etiology 7 . Patients presumed Familial Hypercholesterolemia ( FH ) genetic analysis perform gene encode lowdensity lipoprotein receptor ( LDLR ) , ApoB PCSK9 gene diseasecausing mutation identify 8 . Patients presume FH unclear family history 9 . Patients autosomal recessive hypercholesterolemia ( homozygous FH ) 10 . Patients autosomal recessive low HDL unknown etiology Also , patient must meet following : Patient patient 's parent legal guardian ( applicable ) consent participate study provide informed consent prior study procedure perform . If patient minor age ; he/she willing provide assent require per local regulation , deem able . Patient willing able comply protocol requirement . Patients fall one aforementioned category ( cohort ) consider highly suspicious LAL D test rule disorder outside study discretion Investigator . Active viral hepatitis ; Other confirm genetic liver disease ( e.g. , Wilson 's disease , hemochromatosis , alpha 1antitrypsin ) .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>LAL D</keyword>
	<keyword>CESD</keyword>
	<keyword>NASH</keyword>
	<keyword>NAFLD</keyword>
	<keyword>Wilson 's</keyword>
	<keyword>Niemann Pick</keyword>
	<keyword>Familial Hypercholesterolemia</keyword>
</DOC>